PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Faces Shareholder Lawsuit Over CagriSema Trial Fraud Allegations

Novo Nordisk is reportedly facing a shareholder lawsuit that accuses the company of fraud related to its CagriSema trial.

28 Jul, 18:08 — 28 Jul, 18:08
PostShare

Sources

Showing 1 of 1 sources